SK15552003A3 - Oxadiazolové a tiadiazolové deriváty pyrolidínu, spôsob ich výroby, farmaceutický prostriedok s ich obsahom a ich použitie - Google Patents
Oxadiazolové a tiadiazolové deriváty pyrolidínu, spôsob ich výroby, farmaceutický prostriedok s ich obsahom a ich použitie Download PDFInfo
- Publication number
- SK15552003A3 SK15552003A3 SK1555-2003A SK15552003A SK15552003A3 SK 15552003 A3 SK15552003 A3 SK 15552003A3 SK 15552003 A SK15552003 A SK 15552003A SK 15552003 A3 SK15552003 A3 SK 15552003A3
- Authority
- SK
- Slovakia
- Prior art keywords
- biphenyl
- oxadiazol
- ylcarbonyl
- pyrrolidinone
- methyloxime
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01113632 | 2001-06-18 | ||
PCT/EP2002/006629 WO2002102799A2 (fr) | 2001-06-18 | 2002-06-14 | Derives de pyrrolidine oxadiazoles et thiadiazoles |
Publications (1)
Publication Number | Publication Date |
---|---|
SK15552003A3 true SK15552003A3 (sk) | 2004-05-04 |
Family
ID=8177641
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK1555-2003A SK15552003A3 (sk) | 2001-06-18 | 2002-06-14 | Oxadiazolové a tiadiazolové deriváty pyrolidínu, spôsob ich výroby, farmaceutický prostriedok s ich obsahom a ich použitie |
Country Status (27)
Country | Link |
---|---|
US (2) | US7115639B2 (fr) |
EP (1) | EP1444225B1 (fr) |
JP (1) | JP4426284B2 (fr) |
KR (1) | KR20040030678A (fr) |
CN (1) | CN100564378C (fr) |
AR (1) | AR036108A1 (fr) |
AU (1) | AU2002319237B2 (fr) |
BG (1) | BG108424A (fr) |
BR (1) | BR0211030A (fr) |
CA (1) | CA2449578C (fr) |
CZ (1) | CZ20033475A3 (fr) |
EA (1) | EA006212B1 (fr) |
EE (1) | EE200400022A (fr) |
ES (1) | ES2397305T3 (fr) |
HK (1) | HK1074204A1 (fr) |
HR (1) | HRP20031017A2 (fr) |
HU (1) | HUP0400238A2 (fr) |
IL (1) | IL159219A0 (fr) |
MX (1) | MXPA03011441A (fr) |
MY (1) | MY128890A (fr) |
NO (1) | NO20035399L (fr) |
PL (1) | PL367275A1 (fr) |
RS (1) | RS99503A (fr) |
SK (1) | SK15552003A3 (fr) |
UA (1) | UA75145C2 (fr) |
WO (1) | WO2002102799A2 (fr) |
ZA (1) | ZA200309402B (fr) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1444225B1 (fr) | 2001-06-18 | 2012-10-10 | Merck Serono SA | Derives de pyrrolidine oxadiazoles et thiadiazoles utilisees en tant qu'antagonistes de l'oxytocine |
JP4773335B2 (ja) * | 2003-02-27 | 2011-09-14 | メルク セローノ ソシエテ アノニム | オキシトシンアンタゴニストとしてのピロリジン誘導体 |
DK1725526T3 (da) * | 2004-02-26 | 2008-03-03 | Serono Lab | Fremgangsmåde til fremstilling af pyrrolidinoximer |
KR101562549B1 (ko) | 2005-05-10 | 2015-10-23 | 인사이트 홀딩스 코포레이션 | 인돌아민 2,3-디옥시게나제의 조절제 및 이의 사용방법 |
CA2634198C (fr) | 2005-12-20 | 2014-06-03 | Incyte Corporation | N-hydroxyamidinoheterocycles en tant que modulateurs d'indoleamine 2,3-dioxygenase |
WO2008036642A2 (fr) * | 2006-09-19 | 2008-03-27 | Incyte Corporation | N-hydroxyamidinohétérocycles en tant que modulateurs d'indoléamine 2,3-dioxygénase |
CL2007002650A1 (es) | 2006-09-19 | 2008-02-08 | Incyte Corp | Compuestos derivados de heterociclo n-hidroxiamino; composicion farmaceutica, util para tratar cancer, infecciones virales y desordenes neurodegenerativos entre otras. |
EA029781B1 (ru) | 2008-07-08 | 2018-05-31 | Инсайт Корпорейшн | 1,2,5-оксадиазолы в качестве ингибиторов индоламин-2,3-диоксигеназы |
EP2845850A1 (fr) | 2013-09-10 | 2015-03-11 | ObsEva S.A. | Dérivés de pyrrolidine comme antagonistes des récepteurs V1a de vasopressine/oxytocine |
SI3066085T1 (sl) | 2013-11-08 | 2020-08-31 | Incyte Holdings Corporation | Postopek sinteze inhibitorja indolamina 2,3-dioksigenaze |
EP2886107A1 (fr) | 2013-12-17 | 2015-06-24 | ObsEva S.A. | Formules orales de dérivés de pyrrolydine |
EA031353B1 (ru) | 2014-07-02 | 2018-12-28 | Обсева Са | Кристаллический о-метилоксим (3z,5s)-5-(гидроксиметил)-1-[(2'-метил-1,1'-бифенил-4-ил)карбонил]пирролидин-3-он, полезный в способах лечения состояний, связанных с активностью ot-r |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2722190B1 (fr) | 1994-07-05 | 1996-10-04 | Sanofi Sa | Derives de 1-benzyl-1,3-dihydro-2h-benzimidazol-2-one, leur preparation, les compositions pharmaceutique en contenant |
CA2210138A1 (fr) | 1995-01-24 | 1996-08-01 | Peter D. Williams | Antagonistes tocolytiques des recepteurs de l'oxytocine |
US5756497A (en) | 1996-03-01 | 1998-05-26 | Merck & Co., Inc. | Tocolytic oxytocin receptor antagonists |
FR2757157B1 (fr) | 1996-12-13 | 1999-12-31 | Sanofi Sa | Derives d'indolin-2-one, procede pour leur preparation et compositions pharmaceutiques les contenant |
EP1176959B1 (fr) * | 1999-05-05 | 2006-03-08 | Merck & Co., Inc. | Prolines en tant qu'agents antimicrobiens |
EP1268418B1 (fr) * | 2000-03-27 | 2006-06-14 | Applied Research Systems ARS Holding N.V. | Derives de la pyrrolidine pharmaceutiquement actifs comme inhibiteurs de bax |
US7211601B2 (en) * | 2000-03-27 | 2007-05-01 | Applied Research Systems Ars Holding N.V. | Pharmaceutically active pyrrolidine derivatives |
WO2002032864A1 (fr) * | 2000-10-17 | 2002-04-25 | Applied Research Systems Ars Holding N.V. | Derives de sulfanilide actifs du point de vue pharmaceutique |
ES2303854T3 (es) * | 2001-03-20 | 2008-09-01 | Laboratoires Serono Sa | Derivados de ester de pirrolidina con actividad moduladora de oxitocina. |
EP1444225B1 (fr) | 2001-06-18 | 2012-10-10 | Merck Serono SA | Derives de pyrrolidine oxadiazoles et thiadiazoles utilisees en tant qu'antagonistes de l'oxytocine |
DE60207755T2 (de) * | 2001-12-20 | 2006-07-27 | Applied Research Systems Ars Holding N.V. | Triazole als oxytocin-antagonisten |
UA78058C2 (en) * | 2002-07-05 | 2007-02-15 | Applied Research Systems | Pyrrolidine derivative as oxitocin antagonists |
-
2002
- 2002-06-14 EP EP02748785A patent/EP1444225B1/fr not_active Expired - Lifetime
- 2002-06-14 CN CNB028159446A patent/CN100564378C/zh not_active Expired - Fee Related
- 2002-06-14 SK SK1555-2003A patent/SK15552003A3/sk not_active Application Discontinuation
- 2002-06-14 ES ES02748785T patent/ES2397305T3/es not_active Expired - Lifetime
- 2002-06-14 EA EA200400049A patent/EA006212B1/ru not_active IP Right Cessation
- 2002-06-14 AU AU2002319237A patent/AU2002319237B2/en not_active Ceased
- 2002-06-14 RS YU99503A patent/RS99503A/sr unknown
- 2002-06-14 US US10/480,992 patent/US7115639B2/en not_active Expired - Fee Related
- 2002-06-14 BR BR0211030-0A patent/BR0211030A/pt not_active IP Right Cessation
- 2002-06-14 KR KR10-2003-7016485A patent/KR20040030678A/ko not_active Application Discontinuation
- 2002-06-14 UA UA20031211897A patent/UA75145C2/uk unknown
- 2002-06-14 JP JP2003506272A patent/JP4426284B2/ja not_active Expired - Fee Related
- 2002-06-14 CZ CZ20033475A patent/CZ20033475A3/cs unknown
- 2002-06-14 CA CA2449578A patent/CA2449578C/fr not_active Expired - Fee Related
- 2002-06-14 IL IL15921902A patent/IL159219A0/xx unknown
- 2002-06-14 WO PCT/EP2002/006629 patent/WO2002102799A2/fr not_active Application Discontinuation
- 2002-06-14 EE EEP200400022A patent/EE200400022A/xx unknown
- 2002-06-14 MX MXPA03011441A patent/MXPA03011441A/es active IP Right Grant
- 2002-06-14 PL PL02367275A patent/PL367275A1/xx not_active Application Discontinuation
- 2002-06-14 HU HU0400238A patent/HUP0400238A2/hu unknown
- 2002-06-18 MY MYPI20022260A patent/MY128890A/en unknown
- 2002-06-21 AR ARP020102353A patent/AR036108A1/es unknown
-
2003
- 2003-12-03 ZA ZA200309402A patent/ZA200309402B/en unknown
- 2003-12-04 NO NO20035399A patent/NO20035399L/no unknown
- 2003-12-08 HR HR20031017A patent/HRP20031017A2/xx not_active Application Discontinuation
- 2003-12-08 BG BG108424A patent/BG108424A/xx unknown
-
2005
- 2005-09-16 HK HK05108106.9A patent/HK1074204A1/xx not_active IP Right Cessation
-
2006
- 2006-06-09 US US11/449,802 patent/US20060229343A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20060229343A1 (en) | Pyrrolidine oxadiazole-and thiadiazole oxime derivatives being oxytocin receptor antagonists | |
AU769449B2 (en) | Piperidines as CCR5 modulators | |
KR100862879B1 (ko) | Hiv 인테그라제의 n-치환된 하이드록시피리미디논 카복스아미드 억제제 | |
US20080167318A1 (en) | Pharmaceutically active pyrrolidine derivatives | |
JP4602672B2 (ja) | プロスタグランジンf受容体のモジュレーターとしてのチアゾリジンカルボキサミド誘導体 | |
KR20150092232A (ko) | Cb2 작용제로 유용한 피리딘-2-아마이드 | |
US20070129381A1 (en) | Pharmaceutically active pyrrolidine ester derivatives | |
BR112018011562B1 (pt) | Novos derivados de fenil | |
AU2001256209A1 (en) | Pharmaceutically active pyrrolidine derivatives | |
CN113348168A (zh) | 杂环衍生物 | |
AU2002319237A1 (en) | Pyrrolidine oxadiazole- and thiadiazole oxime derivatives being oxytocin receptor antagonists | |
JP4773335B2 (ja) | オキシトシンアンタゴニストとしてのピロリジン誘導体 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC9A | Refused patent application |